Trial intelligence / Profile preview

Efficacy of ASAQ and AL for Uncomplicated Falciparum Malaria in Burkina Faso

NCT01697787Phase 4Completed

Sponsor
Centre Muraz
Start
Oct 2012
Primary completion
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of artesunate + amodiaquine, artemether + lumefantrine in malaria, sponsored by Centre Muraz. Started Oct 2012; status: completed.

02

Drugs

artesunate + amodiaquineartemether + lumefantrine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT01697787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01697787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call